InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Johnson Waynick Denelle, Executive. Director active across 1 company, notably UCB. Aggregated, 2 reports have been published. History available since 1 April 2026. The latest transaction was filed on 2 April 2026 (Purchase). Regulator: FSMA. All data is openly available.
Declarations2 total
3,873 shares0ShareOff exchangeFSMA:ucb-108
Ideal exit: 27 Dec 2026 (T+270)
2,464 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-190
Ideal exit: 28 Dec 2026 (T+270)
2 of 2 declarations
About Johnson Waynick Denelle
Denelle Johnson Waynick is a senior executive at UCB, a biopharmaceutical company. She is responsible for managing operations and product innovation. Her expertise contributes to the growth and reputation of UCB in the market.
